WEBNF vs. CHGCY
WEBNF (Westpac Banking Corp) and CHGCY (Chugai Pharmaceutical Co Ltd ADR) are both stocks. WEBNF operates in Banks - Diversified (Financial Services), while CHGCY operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, WEBNF returned 14.12%/yr vs 15.87%/yr for CHGCY. At a 0.08 correlation, their price movements are largely independent.
Performance
WEBNF vs. CHGCY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, WEBNF achieves a 0.20% return, which is significantly higher than CHGCY's -9.40% return. Over the past 10 years, WEBNF has underperformed CHGCY with an annualized return of 14.12%, while CHGCY has yielded a comparatively higher 15.87% annualized return.
WEBNF
- 1D
- -0.21%
- 1M
- -4.68%
- YTD
- 0.20%
- 6M
- 7.01%
- 1Y
- 24.75%
- 3Y*
- 29.50%
- 5Y*
- 11.82%
- 10Y*
- 14.12%
CHGCY
- 1D
- -0.63%
- 1M
- -9.64%
- YTD
- -9.40%
- 6M
- -8.99%
- 1Y
- -10.93%
- 3Y*
- 20.51%
- 5Y*
- 5.43%
- 10Y*
- 15.87%
WEBNF vs. CHGCY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
WEBNF Westpac Banking Corp | 0.20% | 39.75% | 34.48% | 5.37% | 10.13% | 52.61% | -8.36% | 6.69% | -16.10% | 23.08% |
CHGCY Chugai Pharmaceutical Co Ltd ADR | -9.40% | 21.53% | 17.55% | 48.78% | -21.63% | -38.50% | 72.01% | 59.87% | 13.53% | 72.59% |
Correlation
The correlation between WEBNF and CHGCY is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since Nov 24, 2010 | 0.08 |
Fundamentals
WEBNF:
$62.48B
CHGCY:
$78.34B
WEBNF:
$5.69
CHGCY:
$144.42
WEBNF:
4.43
CHGCY:
0.16
WEBNF:
0.54
CHGCY:
0.01
WEBNF:
0.80
CHGCY:
0.06
WEBNF:
0.88
CHGCY:
0.04
WEBNF:
$77.68B
CHGCY:
$1.36T
WEBNF:
$43.56B
CHGCY:
$970.13B
WEBNF:
$10.94B
CHGCY:
$699.55B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WEBNF vs. CHGCY — Risk / Return Rank
WEBNF
CHGCY
WEBNF vs. CHGCY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Westpac Banking Corp (WEBNF) and Chugai Pharmaceutical Co Ltd ADR (CHGCY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| WEBNF | CHGCY | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.51 | -0.25 | +0.75 |
Sortino ratioReturn per unit of downside risk | 1.06 | -0.04 | +1.09 |
Omega ratioGain probability vs. loss probability | 1.15 | 0.99 | +0.16 |
Calmar ratioReturn relative to maximum drawdown | 1.20 | -0.24 | +1.44 |
Martin ratioReturn relative to average drawdown | 3.36 | -0.52 | +3.87 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| WEBNF | CHGCY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.51 | -0.25 | +0.75 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.29 | 0.16 | +0.13 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.36 | 0.48 | -0.12 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.18 | 0.51 | -0.33 |
Drawdowns
WEBNF vs. CHGCY - Drawdown Comparison
The maximum WEBNF drawdown since its inception was -66.96%, which is greater than CHGCY's maximum drawdown of -59.68%. Use the drawdown chart below to compare losses from any high point for WEBNF and CHGCY.
Loading charts...
Drawdown Indicators
| WEBNF | CHGCY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -66.96% | -59.68% | -7.28% |
Max Drawdown (1Y)Largest decline over 1 year | -20.54% | -30.79% | +10.25% |
Max Drawdown (3Y)Largest decline over 3 years | -23.44% | -33.18% | +9.74% |
Max Drawdown (5Y)Largest decline over 5 years | -31.14% | -45.45% | +14.31% |
Max Drawdown (10Y)Largest decline over 10 years | -61.21% | -59.68% | -1.53% |
Current DrawdownCurrent decline from peak | -17.57% | -29.19% | +11.62% |
Average DrawdownAverage peak-to-trough decline | -21.03% | -16.07% | -4.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.37% | 14.06% | -6.69% |
Volatility
WEBNF vs. CHGCY - Volatility Comparison
Westpac Banking Corp (WEBNF) has a higher volatility of 11.84% compared to Chugai Pharmaceutical Co Ltd ADR (CHGCY) at 10.86%. This indicates that WEBNF's price experiences larger fluctuations and is considered to be riskier than CHGCY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| WEBNF | CHGCY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.84% | 10.86% | +0.98% |
Volatility (6M)Calculated over the trailing 6-month period | 32.54% | 31.78% | +0.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 48.91% | 44.89% | +4.02% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 41.25% | 34.58% | +6.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.33% | 33.01% | +6.32% |
Dividends
WEBNF vs. CHGCY - Dividend Comparison
WEBNF has not paid dividends to shareholders, while CHGCY's dividend yield for the trailing twelve months is around 1.79%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHGCY Chugai Pharmaceutical Co Ltd ADR | 1.79% | 1.62% | 0.86% | 0.00% | 1.19% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.64% | 1.41% |
WEBNF Westpac Banking Corp | 0.00% | 2.78% | 8.39% | 8.91% | 7.82% | 42.62% | 3.83% | 14.51% | 19.31% | 16.01% | 0.00% | 0.00% |
Financials
WEBNF vs. CHGCY - Financials Comparison
This section allows you to compare key financial metrics between Westpac Banking Corp and Chugai Pharmaceutical Co Ltd ADR. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
WEBNF vs. CHGCY - Profitability Comparison
WEBNF - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Westpac Banking Corp reported a gross profit of 11.02B and revenue of 28.03B. Therefore, the gross margin over that period was 39.3%.
CHGCY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Chugai Pharmaceutical Co Ltd ADR reported a gross profit of 233.16B and revenue of 327.66B. Therefore, the gross margin over that period was 71.2%.
WEBNF - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Westpac Banking Corp reported an operating income of 4.92B and revenue of 28.03B, resulting in an operating margin of 17.6%.
CHGCY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Chugai Pharmaceutical Co Ltd ADR reported an operating income of 165.66B and revenue of 327.66B, resulting in an operating margin of 50.6%.
WEBNF - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Westpac Banking Corp reported a net income of 3.42B and revenue of 28.03B, resulting in a net margin of 12.2%.
CHGCY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Chugai Pharmaceutical Co Ltd ADR reported a net income of 117.54B and revenue of 327.66B, resulting in a net margin of 35.9%.
Frequently Asked Questions
WEBNF and CHGCY have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
WEBNF has higher volatility (11.84%) compared to CHGCY (10.86%). In terms of maximum drawdown, WEBNF dropped -66.96% vs CHGCY's -59.68%.
WEBNF currently has the higher Sharpe Ratio (0.51 vs -0.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for WEBNF and CHGCY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer